22 Followers on Owler
MolecularMD is a molecular diagnostic laboratory that develops and commercializes oncology precision medicines...
Read moreMolecularMD is a molecular diagnostic laboratory that develops and commercializes oncology precision medicines...
Read more
2005
2836 NAICS listing
News
Mar 04, 2019
The Business Journals: Portland
MolecularMD: Portland biotech firm sold to global drug developer
Feb 28, 2019
FierceBiotech
MolecularMD: Icon snaps up molecular DX specialist MolecularMD for undisclosed price
Feb 22, 2019
Contract Pharma
MolecularMD: ICON Acquires MolecularMD
Nov 28, 2018
Genomeweb
MolecularMD: Sysmex, MolecularMD to Collaborate for CDx Development, Commercialization
Nov 13, 2018
4-traders
MolecularMD: First quantitative diagnostic test validated for Treatment-Free Remission for Eligible Patients with Ph+ CML-CP Treated with Tasigna� Cleared by Health Canada
Aug 22, 2018
4-traders
MolecularMD: MolecularMD Launches Validated Tumor Mutation Burden Assay for Immuno-Oncology Clinical Trial Services
Aug 08, 2018
BioPortfolio
MolecularMD: MolecularMD Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Jun 25, 2018
MolecularMD Youtube Channel
MolecularMD posted a video "2018 CMS Annual Laboratory Public Meeting" on YOUTUBE
Jun 04, 2018
PharmiWeb
MolecularMD: MolecularMD and Genoptix Enter into a Definitive Agreement to Market the MRDx® BCR-ABL Test, a Companion Diagnostic for Treatment-free Remission in Ph+ CML-CP Patients Treated with Tasigna®
Dec 23, 2017
PharmiWeb
MolecularMD: MolecularMD obtains FDA Authorization for the MRDx® BCR-ABL Test as a Companion Diagnostic for Treatment-Free Remission in Ph+ CML-CP Patients Treated with Tasigna
MolecularMD Competitors
1
2
3
4
5
6
7
8
9
10
Looking for similar companies to MolecularMD?
MolecularMD News
MolecularMD Press Releases
MolecularMD Videos
MolecularMD Headquarters
MolecularMD Summary
ABOUT
Overview
MolecularMD is a molecular diagnostic laboratory that develops and commercializes oncology precision medicines. MolecularMD was founded in 2005. MolecularMD's headquarters is located in Portland, Oregon, USA 97219. MolecularMD's President & CEO, Dan ...CEO
MolecularMD's President & CEO, Dan Snyder, currently has an approval rating of 79%. MolecularMD's primary competitors are Myriad, Biocept, Ambry Genetics and 28 more.Website
molecularmd.comCompetitors
View 31 MolecularMD competitors here.Acquisitions
There have been no acquisitions found related to MolecularMDInvestments
View 1 MolecularMD investments here.Frequently Asked Questions about MolecularMD
When was MolecularMD founded?
MolecularMD was founded in 2005Who is MolecularMD's CEO?
MolecularMD's CEO is Dan SnyderHow much revenue does MolecularMD generate?
MolecularMD generates $10M in revenueHow much funding does MolecularMD have?
MolecularMD has historically raised $19.1M in fundingWhere is MolecularMD's headquarters?
MolecularMD's headquarters is in Portland Oregon, USA
How many employees does MolecularMD have?
MolecularMD has 125 employeesWhat sector does MolecularMD operate in?
MolecularMD is in BiotechnologyWho are MolecularMD's competitors?
MolecularMD's top competitors are Myriad, Biocept, Ambry GeneticsWho has MolecularMD invested in?
MolecularMD's has invested in companies such as Provista Diagnostics